---
figid: PMC7352943__cancers-12-01421-g002
figlink: pmc/articles/PMC7352943/figure/cancers-12-01421-f002/
number: F2
caption: Oncogenic H-Ras plays a major role in tumor transformation via two major
  pathways, PI3K/AKT and MEK/ERK [,]. H-Ras recruits intracellular Gal-1 from the
  cytosol. This interaction enhances H-Ras-mediated cell transformation. Since Gal-1
  has no effect on the membrane localization of inactive H-Ras, Ras activation, via
  GTP binding is needed for the H-Ras/Gal-1 interaction. Gal-1 is then able to enhance
  H-Ras-GTP, leading to an increase in Raf-1 recruitment, which culminates in a sustained
  activation of the MEK-ERK pathway and enhanced cell transformation [].
pmcid: PMC7352943
papertitle: Galectins and Ovarian Cancer.
reftext: Chisa Shimada, et al. Cancers (Basel). 2020 Jun;12(6):1421.
pmc_ranked_result_index: '76691'
pathway_score: 0.9521797
filename: cancers-12-01421-g002.jpg
figtitle: 'Oncogenic H-Ras plays a major role in tumor transformation via two major
  pathways, PI3K/AKT and MEK/ERK '
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7352943__cancers-12-01421-g002.html
  '@type': Dataset
  description: Oncogenic H-Ras plays a major role in tumor transformation via two
    major pathways, PI3K/AKT and MEK/ERK [,]. H-Ras recruits intracellular Gal-1 from
    the cytosol. This interaction enhances H-Ras-mediated cell transformation. Since
    Gal-1 has no effect on the membrane localization of inactive H-Ras, Ras activation,
    via GTP binding is needed for the H-Ras/Gal-1 interaction. Gal-1 is then able
    to enhance H-Ras-GTP, leading to an increase in Raf-1 recruitment, which culminates
    in a sustained activation of the MEK-ERK pathway and enhanced cell transformation
    [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - GDP
genes:
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: GDP
  source: MESH
  identifier: D006153
diseases: []
figid_alias: PMC7352943__F2
redirect_from: /figures/PMC7352943__F2
figtype: Figure
---
